We demonstrated that circulating sortilin levels are associated with PAD in diabetic patients, that sortilin levels correlate with disease severity and that, therefore, sortilin is a promising marker for PAD in diabetic patients. This evidence concerns the gene SORT1 and peripheral arterial disease.